京都大の山中伸弥教授が、人工多能性幹細胞（iPS細胞）の作製を発表してから今月で20年がたちました。iPS細胞はさまざまな臓器や組織を構成する細胞に変化でき、再生医療や新薬の開発 ...
The Centre has appointed Indian Police Service (IPS) officer Mahesh Dixit as the next Intelligence Bureau (IB) chief, according to people familiar with the matter. A 1993-batch IPS officer, Mahesh ...
An advisory panel to the health minister on Wednesday approved Sumitomo Pharma’s Parkinson’s disease treatment Amchepry, which costs ¥55.3 million ($350,600) per patient, to be covered under the ...
Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Marguerita is a Certified Financial Planner (CFP), Chartered ...
バイオ新興企業のオリヅルセラピューティクス（神奈川県藤沢市）はiPS細胞由来の膵臓（すいぞう）細胞を糖尿病患者に移植する臨床試験（治験）を始める。2027年度にも日本と米国で ...
武田薬品工業と京都大学iPS細胞研究所は2月、10年間にわたる共同研究の成果を発表。写真は武田薬品のクリストフ・ウェバー社長CEO（右）と山中伸弥教授Photo:医薬経済社 ＊本記事は医薬経済 ...
株式会社iPSポータル（本社：京都市左京区、社長：小林 正和、以下「iPSポータル」）と公益財団法人京都大学iPS細胞研究財団（本部：京都府京都市、理事長：山中伸弥、以下iPS財団）は ...
Japan’s health ministry panel on Thursday approved the commercialisation of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. The two drugs, ReHeart ...
A panel of experts on Thursday gave the green light for the health minister to approve the production and sale of two regenerative medical products that use induced pluripotent stem, or iPS, cells.
GREENVILLE, S.C.--(BUSINESS WIRE)--Integrated Power Services (“IPS”) has entered into a definitive agreement to acquire TechPro Power Group, Inc. (“TechPro”), strengthening its position as a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results